Current Trials

To get notified of upcoming trials via Facebook visit our Q-Pharm Facebook page and 'like us'!

HAVE YOU BEEN RECEIVING OUR TRIAL NOTIFICATION EMAILS?

If you are registered on our volunteer database to receive trial notifications via email, please add the following email address to your safe senders list to ensure that you receive the notifications: volunteers@qpharm.com.au

For further information on any of the trials listed below please contact Q-Pharm Recruitment on 1300 QPHARM (1300 774 276) or email us at volunteers@qpharm.com.au

Please note all trials are conducted at our clinic located in the Clive Berghofer Cancer Research Centre, Level 5, 300c Herston Road HERSTON QLD 4006.

General Advertisment for Participants
Study code	Study overview	Eligibility Criteria Required	Visit schedule summary	Approximate visit dates
General Further Information	Volunteers required to participate in clinical trials of new drugs and vaccines.	- Healthy Females and Males. - Aged between 18 to 85 years. - BMI between 18 and 32.	- Screening medical. - In addition some trials may require a number of clinic visit for 1 – 2 hour periods and or in-house stays at Q-Pharm clinic from 12 hours or as long as 7 days.	-Trial dependent. *Please register via the 'Volunteer Registration' section under the 'Volunteers' tab.*

Healthy Participants
Study code	Study overview	Eligibility Criteria Required	Visit schedule summary	Approximate visit dates
QP12C01	Clinical trial to compare collection methods for a hormone test	- Males only - Aged 18 to 50 years	- Able to attend clinic for half a day to complete medical and study day	1st and 2nd March, 2012
QP11C18	Clinical trial of a treatment for movement disorders	- Male or Female - 18 to 50 years old - BMI between 18 and 27kg/m2	- Able to attend up to 2 medical screening appointments - 17 day stay at our clinic	Confinement commencing March, 2012
QP11C19	Clinical trial of an investigational vaccine for Influenza A	- Male or Female - 18 to 55 years old - BMI 19 to 32kg/m2	- Able to attend a screening medical - 2 vaccination visitis - 6 other outpatient visits	Recruitment closed
QP11C14	Clinical trial of a treatment for malaria	- Male or Female - Female must be post-menopausal or no longer able to become pregnant - 18 to 55 years old - Generally healthy BMI 18 - 30	- Able to attend 1 approx 60 hour stay at our clinic - 4 outpatient visits over the following 2 weeks	Various Cohorts running February to May, 2012
QP11C17	Clinical trial to investigate drug treatment for weight loss	- Female - 18 - 60 years - Post Menopausal, surgically sterilised or using a stable dose of implanted or injectable contraceptive - BMI 30 - 45	- Able to attend 10 visits including a 2 overnight confinement period, a screening medical and a number of 4hr outpatient visits over a 5 week period	Cohorts running February to March, 2012
QP11C13	Clinical trial to investigate drug treatment for malaria	- Male - 18 - 45 years - non smoker - Must not have a history of malaria - Unable to donate blood to the ARCBS in the future - Must not have travelled or lived in a malaria-endemic country during the past 12 months or planned travel to a malaria-endemic country during the course of the study.	- Able to attend Q-Pharm over a 4 week period including a 1 overnight stay in our clinic and a number of outpatient visits morning and afternoons.	Cohorts running from January to March, 2012
QP11C10	Clinical trial to investigate a treatment for multiple sclerosis.	- Male or female. - Aged 18 to 45 years. - if female, must no longer be able to become pregnant i.e. post menopausal, surgically sterile. - BMI 18 to 29kg/m2 (min 50kg)	- Able to attend Q-Pharm over a 8-11 week period for 3 confinement stays in our clinic and several outpatient visits.	Mid March, 2012

Disease Affected Participants
Study code	Study overview	Eligibility Criteria Required	Visit schedule summary	Approximate visit dates

All studies at Q-Pharm are conducted under Australian and International guidelines for medical research under the approval of a Human Research Ethics Committee that complies with the strict guidelines as set by the National Health and Medical Research Council. Participation in a trial is dependent on fulfilment of trial specific criteria and overseas visitors require appropriate visas for trial participation.